145 related articles for article (PubMed ID: 35797656)
1. Thrombotic Left Main Coronary Artery Occlusion Treated With Bioresorbable Scaffold.
Camacho Freire SJ; Gómez Menchero AE; Garrido JR; Rojas ML; Piris RC; Díaz Fernández JF
Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 35797656
[No Abstract] [Full Text] [Related]
2. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
[No Abstract] [Full Text] [Related]
3. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
4. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
5. Footprint of a Bioresorbable Vascular Scaffold in Computed Tomography Coronary Angiogram at 5-Year Follow-up.
Vijayvergiya R; Kanabar K; Palanivel R; Lal A; Gupta A
J Invasive Cardiol; 2020 May; 32(5):E136-E137. PubMed ID: 32357136
[TBL] [Abstract][Full Text] [Related]
6. Acute Treatment and 5-Year Follow-up of Longitudinal Deformation of a Bioresorbable Scaffold.
Creaney CS; Hanratty CG; Christensen MK; Walsh SJ
J Invasive Cardiol; 2021 Apr; 33(4):E318-E319. PubMed ID: 33794484
[TBL] [Abstract][Full Text] [Related]
7. First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
Rizik DG; Shah MG; Burke RF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):899-901. PubMed ID: 27545489
[TBL] [Abstract][Full Text] [Related]
8. Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.
Sato K; Panoulas VF; Kawamoto H; Naganuma T; Miyazaki T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):116-8. PubMed ID: 25616826
[No Abstract] [Full Text] [Related]
9. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
[No Abstract] [Full Text] [Related]
10. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
[No Abstract] [Full Text] [Related]
11. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
12. Coronary bioresorbable vascular scaffolds: requiescant in pace?
Alfonso F; Cuesta J; Rivero F
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):569-572. PubMed ID: 33622635
[No Abstract] [Full Text] [Related]
13. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
14. Treatment of focal transplant vasculopathy with a bioresorbable coronary artery stent.
Kamdar F; Das G
J Heart Lung Transplant; 2016 Jul; 35(7):943-4. PubMed ID: 27095002
[No Abstract] [Full Text] [Related]
15. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
[No Abstract] [Full Text] [Related]
16. Technical Approaches to Left Main Coronary Intervention: Contemporary Best Practices.
Rab T
Interv Cardiol Clin; 2019 Apr; 8(2):131-147. PubMed ID: 30832938
[TBL] [Abstract][Full Text] [Related]
17. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months.
Kang SH; Kang SJ; Kim WJ
JACC Cardiovasc Interv; 2017 Sep; 10(18):1896-1898. PubMed ID: 28866035
[No Abstract] [Full Text] [Related]
18. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial.
Tijssen RYG; Kerkmeijer LSM; Katagiri Y; Kraak RP; Takahashi K; Kogame N; Chichareon P; Modolo R; Asano T; Nassif M; Kalkman DN; Sotomi Y; Collet C; Hofma SH; van der Schaaf RJ; Arkenbout EK; Weevers APJD; Beijk MAM; Piek JJ; Tijssen JGP; Henriques JP; de Winter RJ; Onuma Y; Serruys PW; Wykrzykowska JJ
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1189-1198. PubMed ID: 30911857
[TBL] [Abstract][Full Text] [Related]
19. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.
Naganuma T; Kawamoto H; Panoulas VF; Latib A; Tanaka A; Mitomo S; Ruparelia N; Jabbour RJ; Chieffo A; Carlino M; Montorfano M; Colombo A
Int J Cardiol; 2017 Nov; 246():26-31. PubMed ID: 28867010
[TBL] [Abstract][Full Text] [Related]
20. Bailout left main bioresorbable vascular scaffolding for the treatment of iatrogenic coronary dissection induced by guiding catheter and sticky ABSORB bioresorbable vascular scaffold balloon.
Yew KL
Int J Cardiol; 2015; 187():527-9. PubMed ID: 25846666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
